support@custommarketinsights.com+1 737 734 2707
  1. Home
  2. Press releases
  3. Global Ultrasound AI Market Size Likely to Grow at a CAGR of…
Press release

Global Ultrasound AI Market Size Likely to Grow at a CAGR of 22% By 2035

Ayush KadamSr. Research AnalystPublished Source Custom Market Insights

Key highlights

  • The ultrasound AI market covers artificial intelligence software built to work alongside ultrasound imaging systems, improving how images are captured, read, and turned into a diagnosis.
  • By Product Type AI software for image analysis and interpretation held the largest product share in 2025.
  • North America leads the global ultrasound AI market.

Overview

The global ultrasound AI market size was estimated at USD 2.09 billion in 2025 and will grow with a CAGR of 22% from 2026 to 2035, reaching USD 15.27 billion by 2035.

Ultrasound AI Market Revenue and Trends

The ultrasound AI market covers artificial intelligence software built to work alongside ultrasound imaging systems, improving how images are captured, read, and turned into a diagnosis. These tools handle automated measurements, flag abnormalities, optimise image quality, and support clinical decisions across cardiology, obstetrics, radiology, and point-of-care settings. Growth has been rapid, and the reasons are fairly clear.

Diagnostic volumes keep rising, healthcare systems are adopting AI more broadly, trained sonographers are in short supply almost everywhere, point-of-care ultrasound continues to spread beyond specialist departments, and deep learning models have improved to the point where real-time guidance during a scan is now practical rather than experimental.

What are the Factors That Have a Significant Contribution to the Growth of the ultrasound AI market?

Demand for intelligent imaging support has climbed as scan volumes grow, as clinicians look to reduce variability between one operator's reading and another's, and as departments come under pressure to move patients through faster. Industry reporting points to consistent gains in detection rates, more standardised measurements, and meaningful help for less experienced operators who would otherwise need a specialist on hand.

With diagnostic accuracy and throughput both under scrutiny, hospitals and clinics are looking for ultrasound AI that works with the imaging equipment they already own rather than requiring them to replace it.

The technology itself has moved quickly. Real-time on-screen guidance, automated organ and lesion detection, more sophisticated quantification tools, and direct integration with ultrasound devices and PACS have all improved diagnostic confidence and shortened the time a study takes. Several other factors are pushing adoption along, including growing institutional commitment to AI-enabled care, wider availability of these tools in emerging markets, and sustained public and private investment in digital health and diagnostic innovation across developed and developing economies alike.

Opportunities Impact Analysis

Impact Factor

Estimated CAGR Impact

Regional Relevance

Market Impact

Rising demand for automated and consistent ultrasound interpretation

+3.9%

Global

Drives adoption across hospitals and clinics

Growth of point-of-care and portable ultrasound

+3.2%

Asia Pacific, Global

Expands AI use beyond traditional imaging departments

Integration of AI with existing ultrasound systems

+2.8%

North America, Europe

Accelerates workflow efficiency and upgrade cycles

Expansion of AI applications in cardiology and obstetrics

+2.5%

Global

Creates specialized high-value clinical segments

Challenges Impact Analysis

Impact Factor

Estimated CAGR Impact

Regional Relevance

Market Impact

Regulatory approval and clinical validation requirements

-2.4%

Global

Extends time-to-market for new AI solutions

Data privacy, security, and interoperability concerns

-2.1%

Europe, North America

Increases implementation complexity

High cost of advanced AI software and integration

-1.9%

Emerging Markets

Limits adoption in resource-constrained settings

Clinician trust and need for explainable AI

-1.7%

Global

Slows full reliance on automated recommendations

Segment Insight

By Product Type

AI software for image analysis and interpretation held the largest product share in 2025. It automates measurements, detects abnormalities, and supports decision-making across several specialties at once, which is why it tends to be the first purchase a department makes.

Radiologists, cardiologists, and sonographers value the consistency more than the speed, and improvements in deep learning have made real-time performance reliable enough for routine use. Clinicians broadly regard these tools as the most direct way to raise diagnostic quality while reducing dependence on individual operator skill.

By Distribution Channel

Most sales run through ultrasound system manufacturers and specialist AI software providers selling directly. That route bundles the software with integration work, clinical training, licensing, and ongoing support, which matters more here than in most software categories because a tool that will not write into the existing reporting system tends to go unused.

Hospitals, imaging centers, and clinics generally prefer working with a single party that can also handle regulatory documentation and keep the software updated as algorithms are revised.

Regional Insights

North America leads the global ultrasound AI market. Healthcare infrastructure is advanced, AI adoption across clinical settings is comparatively far along, and most of the leading imaging and AI companies are headquartered in the region. Regulatory pathways for imaging software are also well established, which shortens the gap between development and deployment. High imaging volumes and substantial R&D investment keep demand steady rather than cyclical.

Asia Pacific is growing fastest. Healthcare infrastructure is expanding, diagnostic imaging demand is rising sharply, and investment in AI and digital health has accelerated alongside broader adoption of point-of-care ultrasound. China, India, Japan, and South Korea are all seeing steady uptake, supported by government digital health programs and local technology development. Workforce shortages are the sharpest driver of all, since automated guidance has more practical value where there are simply not enough trained sonographers to meet demand.

Report Scope
Feature of the Report Details
Market Size in 2026 USD 2.55 billion
Projected Market Size in 2035 USD 15.27 billion
Market Size in 2025 USD 2.09 billion
CAGR Growth Rate 22% CAGR
Base Year 2025
Forecast Period 2026-2035
Key Segment By Component, Application, Deployment, End User and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfil your requirements for research.

Recent Developments

  • In March 2026: Butterfly Network, Inc. received FDA clearance for a fully automated gestational age tool on its handheld platform, reported as the first cleared AI blind-sweep solution for estimating gestational age, allowing non-specialist providers to date a pregnancy in under two minutes without manual fetal biometry. (Source: HLTH — https://hlth.com/insights/news/butterfly-network-wins-fda-clearance-for-ai-ultrasound-tool-in-women-s-health-2026-03-31)
  • In February 2026: GE HealthCare expanded its collaboration with the U.S. Biomedical Advanced Research and Development Authority (BARDA) by roughly USD 35 million, funding AI-powered point-of-care ultrasound tools for lung pathology and intra-abdominal injury assessment in emergency and field settings. (Source: DOTmed — https://www.dotmed.com/news/story/66051)
  • In June and July 2026: Koninklijke Philips N.V. received FDA 510(k) clearance for Elevate Plus, bringing AI automation such as Auto Measure Abdomen and on-cart Koios decision support to its EPIQ Elite and Affiniti systems, and then launched the Alturion ultrasound system with AI-powered workflows aimed at high-volume clinical environments. (Sources: MassDevice — https://www.massdevice.com/philips-fda-clearance-elevate-ai-ultrasound/; Philips)

List of the prominent players in the Ultrasound AI Market:

  • Koninklijke Philips N.V.
  • GE Healthcare
  • Siemens Healthineers AG
  • Canon Medical Systems Corporation
  • Samsung Medison Co. Ltd.
  • Butterfly Network Inc.
  • Caption Health Inc.
  • Exo Imaging Inc.
  • Others

The Ultrasound AI Market is segmented as follows:

By Component

  • Software
  • Services

By Application

  • Radiology
  • Cardiology
  • Obstetrics & Gynecology
  • Others (Musculoskeletal, Emergency Medicine)

By Deployment

  • Cart-Based
  • Handheld / Point-of-Care

By End User

  • Hospitals
  • Diagnostic Imaging Centers
  • Others (Ambulatory Care, Academic Institutions)

Regional Coverage:

North America

  • U.S.
  • Canada
  • Mexico
  • Rest of North America

Europe

  • Germany
  • France
  • U.K.
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Taiwan
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America
Rate this press release

Share this press release

About the author

Ayush Kadam

Sr. Research Analyst

Ayush Kadam is a Senior Market Research Analyst at Custom Market Insights, with over seven years of experience in syndicated and custom market research. He specializes in market sizing, competitive intelligence, industry trends, forecasting, and strategic insights, helping client

View profile and reports

About Custom Market Insights

Custom Market Insights is a market research and advisory company. It publishes syndicated reports across 18+ industries and delivers custom research, feasibility studies and market entry strategy for companies, investors and consultancies.

Sales and media enquiriessupport@custommarketinsights.com
+1 737 734 2707

###